Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention

Phase 3 Unknown 100 enrolled First Affiliated Hospital, Sun Yat-Sen University

RandomizedParallel-groupOpen-labelTreatment

Summary

we hypothesized that periprocedural treatment with intravenous lipo-PGE1 may reduce myocardial injury and improve clinical outcomes in patients undergoing PCI.

Timeline

Start: 2011-01
Primary completion: 2011-12
Completion: 2011-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Alprostadil	Unknown	20 ug	Intravenous

Indications

No indication recorded.